What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
Alejandro Balsa focuses on Rheumatoid arthritis, Immunology, Internal medicine, Arthritis and Allele.
His Rheumatoid arthritis research is multidisciplinary, relying on both Endocrinology, Connective tissue disease, Physical therapy and CXCR5.
The various areas that Alejandro Balsa examines in his Immunology study include Odds ratio, PTPN22, Genetic association and Genotype.
The Internal medicine study combines topics in areas such as Gastroenterology and Surgery.
His Surgery research incorporates themes from Severity of illness, Incidence, Cohort study and Cohort.
Alejandro Balsa combines subjects such as Psoriasis, Synovial fluid, Randomized controlled trial, Lupus erythematosus and Placebo with his study of Arthritis.
His most cited work include:
- New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study (455 citations)
- Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) (441 citations)
- Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. (289 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Immunology, Gastroenterology and Arthritis.
His research investigates the connection with Internal medicine and areas like Surgery which intersect with concerns in Adverse effect.
Alejandro Balsa interconnects Antibody, Disease and Methotrexate in the investigation of issues within Rheumatoid arthritis.
His study on Immunology also encompasses disciplines like
- Allele together with Human leukocyte antigen,
- Genotype, which have a strong connection to Case-control study.
His Infliximab research incorporates elements of Ankylosing spondylitis, Etanercept and Retrospective cohort study.
Alejandro Balsa interconnects Physical therapy and Immunopathology in the investigation of issues within Rheumatology.
He most often published in these fields:
- Internal medicine (59.34%)
- Rheumatoid arthritis (57.92%)
- Immunology (30.50%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (59.34%)
- Rheumatoid arthritis (57.92%)
- In patient (8.75%)
In recent papers he was focusing on the following fields of study:
Alejandro Balsa mainly focuses on Internal medicine, Rheumatoid arthritis, In patient, Rheumatology and Psoriatic arthritis.
Internal medicine is closely attributed to Gastroenterology in his research.
His biological study focuses on Rheumatoid factor.
His Rheumatology research is multidisciplinary, relying on both Vedolizumab, Inflammatory bowel disease, Ulcerative colitis, Orthopedic surgery and Rheumatism.
Alejandro Balsa usually deals with Psoriatic arthritis and limits it to topics linked to BASDAI and Prospective cohort study.
His Autoantibody research is included under the broader classification of Immunology.
Between 2018 and 2021, his most popular works were:
- Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases. (21 citations)
- Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. (15 citations)
- False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign. (13 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
The scientist’s investigation covers issues in Rheumatoid arthritis, Internal medicine, Rheumatology, Psoriatic arthritis and Intensive care medicine.
His Rheumatoid arthritis research is under the purview of Immunology.
He combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
His biological study deals with issues like Methotrexate, which deal with fields such as Drug and Rheumatism.
His work on Secukinumab and Nail psoriasis is typically connected to In patient as part of general Psoriatic arthritis study, connecting several disciplines of science.
Alejandro Balsa has included themes like Treatment outcome, Medical prescription, Biosimilar and Drug Substitution in his Intensive care medicine study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
